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Arrhythmogenic Right Ventricular Cardiomyopathy
ardiovascular Magnetic
esonance in Arrhythmogenic Right
entricular Cardiomyopathy Revisited
omparison With Task Force Criteria and Genotype
rijita Sen-Chowdhry, MA, MBBS, MRCP,*† Sanjay K. Prasad, MD, MRCP,† Petros Syrris, PHD,*
icardo Wage, DCR(R),† Deirdre Ward, MBBS, MRCPI,* Robert Merrifield, PHD,‡
illian C. Smith, MSC,† David N. Firmin, PHD,† Dudley J. Pennell, MD, FACC,†
illiam J. McKenna, MD, DSC, FACC*
ondon, United Kingdom
OBJECTIVES We sought to assess the utility of cardiovascular magnetic resonance (CMR) in the evaluation
of arrhythmogenic right ventricular cardiomyopathy (ARVC) in relation to diagnostic criteria
and genotype.
BACKGROUND Timely diagnosis of ARVC is difficult as clinical findings may be subtle and nonspecific in
early disease. The role of CMR is controversial owing to the absence of a standardized
protocol, insufficient experience with the modality, and inherent difficulties in imaging the
right ventricle.
METHODS Comprehensive CMR examination was performed in 232 patients undergoing evaluation for
suspected ARVC. CMR outcomes were compared with: 1) prospective clinical diagnosis
using Task Force guidelines, with and without the proposed modifications for familial
ARVC; and 2) gene-carrier status in 35 individuals from genotyped families.
RESULTS CMR studies were positive in all 64 patients who prospectively fulfilled Task Force criteria,
resulting in 100% sensitivity. Specificity in relation to Task Force criteria was low (29%). Of
the 119 apparent false positives detected by CMR, however, 63 fulfilled modified diagnostic
criteria for familial ARVC and 7 were obligate gene carriers, suggesting that CMR frequently
identifies individuals with early disease, in whom Task Force criteria are relatively insensitive.
This was borne out by evaluation of genotyped individuals (26 gene-positive and 9
gene-negative), in whom CMR had a sensitivity of 96% and a specificity of 78%.
CONCLUSIONS CMR is a valuable component of the diagnostic workup for ARVC when performed with a
dedicated protocol by specialists with experience in analysis of volumes, right ventricular wall
motion, and delayed-enhancement imaging. (J Am Coll Cardiol 2006;48:2132–40) © 2006
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.07.045by the American College of Cardiology Foundation
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olinical diagnosis of arrhythmogenic right ventricular car-
iomyopathy (ARVC) is frequently confounded by the
onspecific nature of associated findings and the absence of
single, definitive diagnostic test. The 1994 Task Force
TF) diagnostic guidelines aimed to address these difficulties
y differential weighting of structural, histologic, electrocar-
iographic, arrhythmic, and familial features into major and
inor criteria, according to their specificity (1).
Preliminary elucidation of the genetic basis of ARVC
ver the past 5 years has had two-fold results. First, the
solation of disease-causing mutations in plakoglobin, des-
From *Cardiology In The Young, The Heart Hospital, University College London,
he †Cardiovascular Magnetic Resonance Unit, National Heart and Lung Institute,
mperial College, and ‡Wolfson Foundation Medical Image Computing Laboratory,
mperial College, London, United Kingdom. Supported by the British Heart
oundation (Drs. Sen-Chowdhry, Syrris, Ward, and McKenna), the European
ommission 5th Framework Program (ARVC/D project, QLG1-CT-2000-01091),
nd CORDA (Drs. Prasad and Pennell).t
Manuscript received February 27, 2006; revised manuscript received July 12, 2006,
ccepted July 23, 2006.oplakin, plakophilin-2, and desmoglein-2 has suggested a
entral role for impaired cell adhesion in the pathogenesis of
RVC (2,3). Second, the accompanying studies of geno-
ype–phenotype associations have highlighted the limita-
ions of the TF criteria, which were developed at a time
hen clinical experience with ARVC was dominated by
ymptomatic index cases with advanced disease expression
4,5). Consequently, the guidelines are highly specific but
ack sensitivity for early disease. Modified criteria have been
roposed to facilitate diagnosis of familial ARVC in first-
egree relatives with incomplete disease expression (Table 1)
1,6).
Particularly challenging is detection of the so-called
concealed” phase of ARVC, during which clinical mark-
rs are subtle or absent but patients may nonetheless be at
isk of sudden cardiac death (SCD) (1). Strategies to
nable timely diagnosis include clinical implementation
f genetic analysis and development of sensitive imaging
echniques.
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November 21, 2006:2132–40 Reassessing the Role of CMR in ARVCThe role of cardiovascular magnetic resonance (CMR) in
he diagnosis of ARVC remains unresolved. CMR origi-
ally attracted interest as a noninvasive means of tissue
haracterization owing to the ability of fast-spin echo
equences to differentiate fat from normal myocardium.
cquisition of gradient-echo ciné images further allows
ssessment of volumes, function, and regional wall motion
bnormalities (RWMA). Late enhancement (LE) has been
hown to correlate with scarring after myocardial infarction
nd fibrofatty changes in ARVC (7,8). Nevertheless, the
ubjectivity inherent in the interpretation of wall thinning,
ocalized contraction abnormalities, and intramyocardial fat
as generated considerable controversy (9–11). Other crit-
cisms of CMR include the absence of a standardized
rotocol and studies systematically comparing it with other
maging modalities. Studies assessing the diagnostic value of
MR have hitherto been limited by small sample numbers
nd the need to employ the TF criteria as the only available
old standard (11–12).
BJECTIVES
e sought to assess the diagnostic accuracy of CMR in 232
atients undergoing evaluation for suspected ARVC using 3
Abbreviations and Acronyms
ARVC  arrhythmogenic right ventricular
cardiomyopathy
CMR  cardiovascular magnetic resonance
ECG  electrocardiogram
LE  late enhancement
LV  left ventricle/left ventricular
ROC  receiver-operating characteristic
RV  right ventricle/right ventricular
RWMA  regional wall motion abnormalities
SCD  sudden cardiac death
TF  Task Force
able 1. Proposed Modified Criteria for the Diagnosis of
amilial ARVC
ARVC in a first-degree relative plus one of the following otherwise
unexplained abnormalities*:
ECG
T-wave inversion in right precordial leads (V2 and V3)
Signal-averaged ECG
Late potentials seen on signal-averaged ECG
Arrhythmia
LBBB type VT on ECG, on Holter monitoring, or during exercise
testing
VT extrasystoles 200 over a 24-h period
Structural or functional abnormality of the RV
Mild global RV dilatation and/or reduction in ejection fraction with
normal LV
Mild segmental dilatation of the RV
Regional RV hypokinesia
ata from Sen-Chowdhry et al. (1) and Hamid et al. (6). *Applicability is confined
o first-degree relatives who do not fulfill the original Task Force guidelines.
ARVC  arrhythmogenic right ventricular cardiomyopathy; ECG  electrocar-s
iogram; LBBB  left bundle branch block; LV  left ventricle; RV  right
entricle/right ventricular; VT  ventricular tachycardia.ifferent gold standards: 1) TF guidelines; 2) extended
iagnostic criteria, incorporating the proposed modifica-
ions for familial ARVC and obligate gene carriers identi-
ed through pedigree analysis; and 3) gene-carrier status in
he subset of individuals from genotyped families.
ETHODS
tudy protocol. Ethical approval was obtained from local
ommittees, and participating individuals gave informed
onsent. The Heart Hospital is a tertiary referral center with
well-established clinical ARVC service, run in conjunction
ith a genetic screening program. The study population
omprised 232 patients attending either of 2 dedicated
linics between January 2003 and February 2005 for assess-
ent of suspected ARVC. All underwent cardiac evaluation
or ARVC, including clinical history, pedigree analysis,
2-lead electrocardiogram (ECG), signal-averaged ECG,
onventional 2-dimensional echocardiography, exercise
esting, and ambulatory ECG monitoring.
rospective clinical diagnosis. Patients were assigned to
ne or more of the following diagnostic categories indepen-
ently of the results of CMR assessment:
. TF criteria: all patients fulfilling TF diagnostic guide-
lines for ARVC;
. Extended diagnostic criteria, incorporating the follow-
ing:
a. Patients fulfilling original TF guidelines;
b. Patients satisfying modified diagnostic criteria for
familial ARVC (Table 1) (1,6);
c. Obligate gene carriers: individuals who did not satisfy
diagnostic criteria for ARVC, but could be identified
as obligate gene carriers through pedigree analysis.
enotyped subset. Over the 2-year recruitment and 1-year
ollow-up periods, disease-causing mutations were identi-
ed in several ARVC families from the broader Heart
ospital cohort and a number of individuals underwent
redictive testing. As a result, the gene-carrier status of 35
articipating individuals became known.
MR technique. Cardiovascular magnetic resonance was
erformed at the National Heart and Lung Institute,
mperial College, on a 1.5-T Sonata scanner (Siemens
edical Solutions, Erlangen, Germany) using a compre-
ensive dedicated protocol (Table 2) (13–16).
MR readers. Eight data collectors participated in image
cquisition and/or analysis. Clinical and genetic data were
ot available to operators or readers at the CMR unit.
evertheless, familiarity with clinical details was presumed
or the main operator (S.S.C.) owing to her direct involve-
ent in patient care at The Heart Hospital, and she was
egarded as unblinded by default. The remaining data
ollectors were considered independent.
All CMR studies were reviewed by the main operator
S.S.C.) and at least 2 independent readers. The readers
ubjectively classified each scan into 1 of 4 categories:
TP
V
S
E
P
V
W
C
C
L
R
D

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Reassessing the Role of CMR in ARVC November 21, 2006:2132–40able 2. Cardiovascular Magnetic Resonance Protocol
Standard Protocol (All Patients)
rior to study 1. Suppression of frequent PVCs with antiarrhythmic therapy
2. Height and weight recorded; informed consent obtained
iews obtained 4-chamber; 2-chamber; left ventricular outflow tract; RVOT; sequential short-axis slices from level of
atrioventricular valves to apex; sequential transverse slices from level of RVOT to diaphragm
equences and parameters used* 1. Fast imaging with SSFP cine loops (retrospective ECG gating with acquisition window set
15%–20% above average RR interval; 7-mm slice thickness; 3-mm interslice gap for short-axis
and transverse stacks)
Typical parameters: FOVread 300–400 mm; FOVphase 60%–75%; TE 1.48; temporal resolution
20.6–23 ms; base resolution 256; phase resolution 63%; flip angle 60°; average pixel size 1.56 
1.56 mm; bandwidth 977 Hz/pixel; segments 7; 40–45 phases/cycle. Average breath hold 20 s;
acquisition time reduced if necessary by lowering spatial resolution in phase-encode direction
2. T1-weighted turbo spin echo images (6- to 7-mm slice thickness, 3- to 4-mm interslice gap)
Typical parameters: FOVread 300; FOVphase 75%; TE 4.9; TR set between RR and acquisition
window; base resolution 256; phase resolution 75%; average pixel size 1.2  1.2; bandwidth
305 Hz/pixel
3. T2-weighted STIR for fat suppression (7- to 8-mm slice thickness, 2- to 3-mm interslice gap)
Typical parameters: FOVread 300–400; FOVphase 60%–75%; TE 60; TI 170; TR  RR  800
or RR  2; 15 segments using every second trigger pulse; base resolution 256; phase resolution
60%; average pixel size 1.4  1.4; bandwidth 235 Hz/pixel
Extended Protocol
ligibility 1) Age 18 yrs and 2) children ages 15–18 yrs weighing 50 kg
rocedure Peripheral intravenous bolus injection of gadolinium-DTPA (0.1 mmol/kg)
90° presaturation pulse placed over the cerebrospinal fluid to eliminate artefact. Late enhancement
images obtained using a 2-dimensional segmented fast low-angle shot inversion recovery
sequence at least 5 min after contrast administration*; careful optimization of inversion times to
maintain nulling of healthy left ventricular myocardium
Typical parameters: slice thickness 8 mm; interslice gap 2 mm; FOVread 300–400 mm; FOVphase
60%–75%; TE 4; acquisition window set to RR  100 ms; TR approximately equal to
acquisition window; base resolution 256; phase resolution 63%; flip angle 20°; average pixel size
1.56  1.56 mm; bandwidth 230 Hz/pixel; segments 23; TI increasing from 320 to 440
Standard long-axis and all short-axis views acquired twice with different phase-encoding directions
Image Analysis
olumes Ventricular volumes and function assessed from serial short-axis cine loops using CMR Tools
(Cardiovascular Imaging Solutions, London, UK)
Gender-based reference ranges corrected for age and BSA available for patients age 20 yrs (15,16);
volume measurements in younger patients compared with those from age- and gender-matched
control subjects after correcting for BSA
Four ordinal categories also defined:
Normal
Mild ventricular dilation: EDV 117% predicted
Moderate ventricular dilation: EDV 135% predicted
Severe ventricular dilation: EDV 155% predicted
all motion, trabeculation Subjective assessment; localized aneurysms defined as akinetic or dyskinetic regions of the ventricular
wall showing bulging during diastole
riteria for myocardial fat High T1 signal on turbo spin images, with fat suppression on corresponding STIR images
riteria for late enhancement 1. Detection in the same slice after swapping phase encoding, thereby eliminating artefact; and
2. Absence of fat in the same location on corresponding T1-weighted turbo spin echo image
V infiltrate Extent of myocardial fatty replacement and/or late enhancement in the left ventricle visually graded
as follows (according to 17-segment model):
0  nil
1  minor, affecting 2 segments
2  moderate, affecting 3 segments
3  prominent, affecting 4 segments
4  extensive, affecting 5 or more segments
V infiltrate Extent of myocardial fatty replacement and/or late enhancement in the right ventricle visually graded
by intensity (0 to 2) at each site affected (right ventricular outflow tract, subtricuspid region, free
wall, and apex), total ranging from 0 to 8
ata from Simonetti et al. (13) and Maceira et al. (16). *Adjusted to optimize images for individual subjects.
BSA  body surface area; ECG  electrocardiogram; EDV  end-diastolic volume; FOV  field of view; LV  left ventricle; PVC  premature ventricular complex; RV
right ventricle; RVOT  right ventricular outflow tract; SSFP  steady-state free precession; STIR  short Tau inversion recovery.
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November 21, 2006:2132–40 Reassessing the Role of CMR in ARVCiagnostic, in which sufficient hallmark features were rec-
gnized to support a diagnosis of ARVC on the basis of
MR alone; Strongly Suspicious, in which unequivocal
bnormalities consistent with ARVC were identified, but
ere considered insufficient per se to establish a diagnosis
ithout clinical correlation; Possible, in the presence of mild
r nonspecific abnormalities, the significance of which was
ifficult to interpret; or Normal. In instances where one or
ore readers differed in classification of a scan, the concor-
ant opinions were considered final, with more independent
eviews sought if necessary.
For assessment of diagnostic accuracy, Diagnostic and
trongly Suspicious scans were considered positive, whereas
cans classified as Possible or Normal were considered
egative.
ntraobserver variability. Twelve months after the com-
letion of the study (January 2006), the main CMR oper-
tor (S.S.C.) reinterpreted 150 randomly selected CMR
cans from the original cohort. Names and other identifying
etails were removed from the scans before viewing to
nsure blinding. Her subsequent classification of the scans
as compared with her original opinion during the course of
he study as an indicator of intraobserver variability.
nterobserver variability. Concordance with the opinion
f the main CMR operator was assessed for readers who had
eviewed 60 scans as an indicator of interobserver
ariability.
ata analysis. Statistical calculations were performed us-
ng web-based computation facilities (courtesy of Professor
ichard Lowry) (17). Linear weighted kappa concordance
oefficient was calculated as an indicator of intraobserver
nd interobserver variability. The four designations (Diag-
ostic, Strongly Suspicious, Possible, and Normal) were
onsidered ordinal categories. The default relative dis-
ance of 1 was increased to 3 between the Strongly
uspicious and Possible categories to reflect the positive/
egative dichotomy.
Sensitivity, specificity, and positive and negative predic-
ive values were assessed in relation to TF guidelines,
xtended diagnostic criteria, and genotype. The relative
tility of key CMR features (ventricular volumes, RWMA,
ntramyocardial fat, and LE) was evaluated in genotyped
atients. Receiver-operating characteristic (ROC) curve
nalysis was performed for ordinal and categorized contin-
ous variables (18). The presence or absence of each
bnormality was considered a dichotomous variable, and
ssociation with genotype was analyzed using the Fisher
xact probability test.
ESULTS
atient baseline characteristics. The study sample com-
rised 232 patients, ages 34  16 years (range 11 to 76
ears), with an approximately equal male-to-female ratio
0.95:1). Indications for referral were as follows: 34 (15%)
ad symptomatic arrhythmia of right ventricular (RV) erigin; 6 (3%) had cardiac symptoms and electrocardio-
raphic or echocardiographic features that raised suspicion
f ARVC; 1 had recurrent syncope without documented
rrhythmia; 1 was a cardiac arrest survivor with documented
aroxysmal atrial fibrillation but otherwise normal cardiac
ssessment including coronary angiogram; the remainder
ad a family history of ARVC (n  173 [75%]) or SCD
ith cause unascertained (n  17 [7%]).
linical assessment. Based on clinical evaluation before
MR examination, 64 patients (28%) fulfilled TF diagnos-
ic criteria for ARVC. Applying the proposed modifications
or familial ARVC enabled clinical diagnosis in a further 63
atients (27%). Seven patients were identified as obligate
ene carriers based on familial assessment and pedigree
nalysis, but did not satisfy original or modified diagnostic
riteria. A total of 134 patients (58%) therefore fulfilled the
xtended diagnostic criteria as previously defined.
MR studies. Scan duration was 40 to 80 min. The
rotocol was generally well tolerated. Twenty-seven chil-
ren (ages 18) were not eligible for administration of
adolinium-DTPA because of age and weight stipulations.
ive adults declined contrast injections because of needle
hobia or claustrophobia and consequent reluctance to
ndergo the full-length protocol.
MR analysis. During reporting, the readers classified
MR studies as Diagnostic in the presence of moderate to
evere RV dilation and/or impairment, aneurysms, and
arked myocardial fatty replacement or LE. The Strongly
uspicious category included studies with mild to moderate
entricular dilation and/or impairment, prominent
WMA, and/or intramyocardial fat or LE. Scans were
ated Possible in the presence of mild RWMA of uncertain
ignificance and/or volumes at the upper limit of normal.
eproducibility. The intraobserver kappa for the main
perator was 0.87 (range 0.81 to 0.93) (n  150). Three of
he other readers reviewed more than 60 scans. Interob-
erver kappa coefficients were 0.47 (range 0.31 to 0.63) (n
0), 0.58 (range 0.46 to 0.70) (n  110), and 0.84 (range
.76 to 0.92) (n  143).
iagnostic accuracy. The results of CMR examination in
elation to clinical status are shown in Table 3. All 64
atients who prospectively fulfilled TF criteria had unequiv-
cal abnormalities on CMR, resulting in 100% sensitivity.
owever, almost 70% of patients who did not satisfy TF
riteria also had CMR studies Diagnostic or Strongly
uspicious of disease expression. The overall specificity of
MR in relation to TF criteria therefore was only 29%. Of
he 134 patients fulfilling extended diagnostic criteria, all
ad Strongly Suspicious or Diagnostic changes on CMR;
he sensitivity of CMR therefore remained 100%, and the
pecificity increased to 50%. In the 63 patients fulfilling
odified criteria for familial ARVC, inclusion of CMR
bnormalities would have enabled definitive TF diagnosis in
7 (75%).
ossible cases. Of the 35 patients with CMR studies
valuated as Possible, 19 (54%) had nondiagnostic clinical
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Reassessing the Role of CMR in ARVC November 21, 2006:2132–40eatures such as incomplete right bundle branch block,
upraventricular arrhythmia, and/or couplets and bigeminy
n ambulatory ECG monitoring but 200 ventricular
xtrasystoles in 24 h.
enotyped subset. The genotyped subset was composed
f 15 men and 20 women, age 34  16 years (range 11 to
2) from 15 families with distinct mutations in desmoplakin
n  6), plakophilin-2 (n  6), desmoglein-2 (n  2), and
nother cell adhesion protein (n  1) (Syrris P, McKenna
J, unpublished data, March 2006). CMR evaluation was
onducted before mutation screening in 30 individuals from
his subset. Disease-causing mutations were identified in 11
f these patients using a candidate gene strategy; the other
9 received predictive testing after isolation of the causative
ene in their families. In the 5 remaining individuals, CMR
as performed after successful genotyping. Four were from
single family genotyped by linkage analysis. The fifth
nderwent CMR as part of his clinical workup after
redictive testing demonstrated gene-carrier status.
ene-positive patients. Twenty-six of the patients in the
enotyped subset were gene positive. Of these, 12 fulfilled
F guidelines and a further 8 satisfied modified diagnostic
riteria. CMR studies were considered Diagnostic (n  23)
r Strongly Suspicious (n  2) in a total of 25 (96%). The
xception was a boy age 12 whose CMR study was ranked
s Possible on the basis of mild localized dilation at the RV
utflow tract and subtricuspid region. His other investiga-
ions were unremarkable.
Five gene-positive individuals who did not fulfill the
xtended diagnostic criteria were correctly identified by
MR before genotyping: 1) an asymptomatic 19-year-old
oy with marked RV RWMA and prominent left ventric-
lar (LV) LE on CMR. All other investigations were
nremarkable; 2) a boy of 13, in whom biventricular
imensions were at the upper limit of normal on echocar-
iography. CMR volume assessment showed moderate
iventricular dilation in comparison with age- and sex-
atched controls, and RWMAs were observed in both
entricles on CMR; 3) an asymptomatic 47-year-old
oman with incomplete right bundle branch block on
2-lead ECG and LV dimensions at the upper limit of
ormal on echocardiography. CMR showed biventricular
ilation and RV RWMA; 4) a 42-year-old woman with
able 3. Results of CMR Examination in Relationship to Clinica
riteria
Clinical Gold Standard
CMR Study
 
ask Force guidelines
 64 0
 119 49
xtended diagnostic criteria
 134 0
 49 49
MR  cardiovascular magnetic resonance; NPV  negative predictive value; PPVyncope in whom clinical evaluation revealed inverted e-waves in V1 through V6, late potentials on signal-
veraged ECG, and 1,000 ventricular extrasystoles in
4 h. Conventional 2-dimensional echocardiography was
nremarkable. Three minor criteria are insufficient for TF
iagnosis and there was no family history of ARVC,
recluding use of modified criteria. CMR demonstrated
ultiple RV aneurysms, prominent RV fatty replacement,
nd LV LE; and 5) a 48-year-old woman with a longstand-
ng history of palpitation who had recently lost her daughter
o ARVC. Her 12-lead ECG showed inverted T-waves in
1 to V2, insufficient to fulfill modified diagnostic criteria.
isualization of the RV was unsatisfactory on conventional
-dimensional echocardiography; however, CMR showed
oderate biventricular dilation, RV RWMA, and minor
E at the inferolateral LV wall.
ene-negative patients. Among the 9 gene-negative pa-
ients, one 34-year-old woman satisfied TF criteria. Her
other had suffered SCD with confirmation of ARVC on
ostmortem examination. The patient herself had a long-
tanding history of palpitation. A 12-lead ECG and signal-
veraged ECG were normal, but Holter monitoring on one
ccasion showed 400 ventricular extrasystoles including
salvo of nonsustained ventricular tachycardia. Two-
imensional echocardiography showed RV RWMA. Her
MR study was rated as Suspicious, as was that of her
dentical twin sister. A missense mutation in plakophilin
419C¡T) was subsequently isolated in all other clinically
ffected members of the family.
Four CMR studies from gene-negative patients were
lassified as Possible because of abnormal trabeculation (n
), mild localized dilation at the RV subtricuspid region
n  2), and mild LV dilation (n  1). The remaining 3
ene-negative individuals had normal scans.
omparison of diagnostic accuracy. The diagnostic accu-
acy of the TF guidelines, extended criteria, and CMR in
he genotyped sample are compared in Table 4. Again, both
iagnostic and Strongly Suspicious studies were considered
ositive for evaluation of sensitivity and specificity. The area
nder the ROC curve for CMR was 0.98. Inclusion of scans
ated Possible in the positive category would have increased
he sensitivity of CMR from 95% to 100%, at the cost of
educing the specificity from 78% to 33%. Conversely,
ssigning positive status to the Diagnostic scans alone,
tus as Determined by Conventional and Extended Diagnostic
Diagnostic Utility of CMR
nsitivity Specificity PPV NPV
100% 29% 35% 100%
100% 50% 73% 100%
sitive predictive value.l Sta
Sexcluding studies considered Strongly Suspicious, would
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November 21, 2006:2132–40 Reassessing the Role of CMR in ARVCave improved the specificity to 100% while reducing the
ensitivity to 88%.
etrospective diagnosis. Incorporation of both clinical
nd CMR data would have enabled TF diagnosis in 20 of
6 gene-positive patients, improving the sensitivity of the
iagnostic guidelines from 46% to 77% without any reduc-
ion in the 89% specificity.
MR parameters. Of 26 gene-positive patients, CMR
olume analysis showed dilation and/or systolic impairment
f the RV in 20 (77%) and the LV in 14 (54%). In 1
ene-negative patient, a boy age 12, LV volumes were
ildly enlarged compared with age-matched and sex-
able 4. Diagnostic Accuracy of the Task Force Criteria, Extend
tatus in the Genotyped Population (n  35)
True Positive True Negative False P
ask Force guidelines 12 8 1
xtended criteria* 20 8 1
MR 25 7 2
Extended diagnostic criteria refer to the original Task Force guidelines plus the propo
o obligate gene carriers in the genotyped subset.
CMR  cardiovascular magnetic resonance; NPV  negative predictive value; P
igure 1. Cardiovascular magnetic resonance images from a 72-year-old m
he 4-chamber view in diastole (A) and systole (B). Prominent regional w
pex of the right ventricle. Arrows point to the mid-free wall aneurysm. In
D) Late enhancement at the septum, inferoseptal junction, and inferolate
onobstructive coronary artery disease.atched controls. Abnormal trabeculation was reported in
0% of gene carriers, but also in 44% of gene-negative
atients.
Eighteen gene-positive patients (69%) had RV aneurysms
nd/or segmental dilation and RWMA judged to be severe
Figs. 1A and 1B). Marked regional dilation and RWMA
ere not observed in gene-negative patients. In contrast,
ild localized dilation and/or hypokinesia was present in all
ene carriers and 56% of gene-negative patients.
Of the subgroup of 35 genotyped patients, delayed-
nhancement imaging was performed in 28. Five children were
ot eligible according to the study protocol, and 2 adults
iagnostic Criteria, and CMR in Relationship to Gene-Carrier
e False Negative Sensitivity Specificity PPV NPV
14 46% 89% 92% 36%
6 77% 89% 95% 57%
1 96% 78% 93% 88%
difications for familial arrhythmogenic right ventricular cardiomyopathy. There were
positive predictive value.
th a desmoplakin mutation. The steady-state free precession images depict
tion abnormalities were observed at the outflow tract, mid-free wall, and
turbo spin-echo image (C), black arrows indicate areas of myocardial fat.ed D
ositiv
sed moan wi
all mo
the
ral left ventricular wall (white arrows). Angiography showed minor
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Reassessing the Role of CMR in ARVC November 21, 2006:2132–40eclined. LV LE was detected in the 22 gene-positive patients
ho received gadolinium-DTPA in a subepicardial or mid-
yocardial distribution, or both. The extent of LE was minor
n 5, and moderate to extensive in 18 (82%) (Fig. 1D).
inor LE was reported in 2 gene carriers and 2 gene-
egative twin sisters (1 of whom satisfied TF criteria). RV
E was less easy to distinguish from intramyocardial fat, but
as considered unequivocal in 13 gene carriers and no
ene-negative individuals. Fatty replacement of the RV
yocardium (Fig. 1C) was identified in 65% of gene-
ositive patients and the sole gene-negative patient who
ulfilled TF criteria.
The diagnostic value of various CMR parameters is
hown in Table 5, together with the area under the ROC
urve, where applicable. The parameters showing the stron-
est association with gene-carrier status were abnormal RV
olumes, severe segmental dilation and/or RV aneurysms,
nd LV LE.
ISCUSSION
he past decade has seen gradual evolution in clinical
erception of CMR assessment for suspected ARVC. Initial
nthusiasm for a noninvasive technique that is not restricted
y acoustic windows was tempered by concerns regarding
nterobserver variability, lack of experience with the modal-
ty at most imaging centers, insufficient resolution for
etection of wall thinning, overinterpretation of RWMA,
nd difficulties in differentiating normal epicardial fat from
rue myocardial adipose replacement (9,19). An additional
autionary note was the paucity of studies assessing its
iagnostic accuracy, albeit in the absence of a true gold
tandard (10,11).
Since genetic analysis remains in its infancy in ARVC
nd is not yet widely available, the initial phase of our study
irrors the approach at most centers, where noninvasive
linical evaluation is the mainstay of diagnosis. Among 232
atients undergoing evaluation for ARVC, the sensitivity of
MR was 100% when applying TF criteria as a gold
tandard. The conspicuously high detection rate may be
ttributed, at least in part, to the limitations of the TF
uidelines, which reflect the overt form of the disease that is
able 5. Diagnostic Value and Statistical Significance of CMR P
CMR Parameter Sensitivity
olume analysis
LV dilation and/or systolic impairment 54%
RV dilation and/or systolic impairment 77%
bnormal trabeculation 50%
evere RV segmental dilation/RWMA and/or aneurysms 69%
ild RV localized dilation and/or RWMA 100%
ate enhancement (LV)† 100%
ate enhancement (RV)† 59%
ntramyocardial fat (RV) 65%
Two-tailed p values are reported to 3 decimal places. †Three children age 18 yrs d
CMR  cardiovascular magnetic resonance; LV  left ventricle; ROC  re
bnormalities.asily recognized. The majority of study patients who fulfilled iF criteria had abnormalities on 2-dimensional echocardiog-
aphy. In patients with structurally severe disease, all imaging
odalities are likely to provide satisfactory evaluation, and
he ability of CMR to do so is therefore not exceptional. In
ontrast, patients with milder phenotypes pose a significant
iagnostic challenge.
White et al. (11) investigated the relative utility of CMR
nd RV angiography in the diagnosis of ARVC. Employing
F criteria as the gold standard, RV angiography had a
pecificity of 100%, whereas that of CMR was only 60%.
he high false-positive rate was ascribed to over-reading of
ubtle RV RWMA detected by CMR. Although our study
licited a still lower specificity for CMR in comparison with
F guidelines (29%), subsequent analysis indicates an alter-
ative explanation. Of the 119 apparent false positives
dentified by CMR, over 50% fulfilled the modified diag-
ostic criteria for familial ARVC and a further 7 were
bligate gene carriers. The obligate gene carriers are of
articular interest because other clinical investigations were
ithin normal limits, whereas the CMR was unequivocally
bnormal. Thus, our results suggest that CMR may be
apable of detecting an early form of ARVC.
Investigation of the genotyped subset lends support to
his hypothesis. The TF guidelines identified 46% of ge-
etically affected individuals; the proposed modifications for
he diagnosis of familial ARVC increased the sensitivity to
7% without any loss in specificity. The specificity of TF
iagnosis in the genotyped sample was 100% because of
he single gene-negative patient who fulfilled criteria, based
n a family history of pathologically proven ARVC, non-
ustained ventricular tachycardia on Holter monitoring, and
V RWMA on echocardiography. The 419C¡T (S140F)
issense mutation in plakophilin-2 isolated in her family
as been reported in other cohorts and is thought to be
athogenic rather than a polymorphism (2,5). Reconciling
he genetic data with the clinical profile is difficult, and
nvolves ascribing the echocardiographic abnormalities to
ver-reading and the arrhythmia to an unrelated cause.
evertheless, we cannot exclude the possibility of a second
utation in this family, and the genotype remains under
eters in Genotyped Sample
cificity Area Under ROC Curve Strength of Association*
89% LV dilation: 0.729 p  0.048
00% RV dilation: 0.846 p  0.001
56% N/A p  NS
00% N/A p  0.001
44% N/A p  0.003
67% LV late enhancement: 0.964 p  0.001
00% RV fat/late enhancement: 0.796 p  0.018
89% p  0.007
receive gadolinium; 2 adults declined because of claustrophobia and needle phobia.
operating characteristic; RV  right ventricle; RWMA  regional wall motionaram
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November 21, 2006:2132–40 Reassessing the Role of CMR in ARVCThe high sensitivity of CMR among genotyped patients
96%) merits further discussion. CMR evaluation in our
tudy differed from standard clinical protocols in several key
spects. First, acquisition of ciné images with high temporal
esolution (23 ms) facilitated accurate volume estimation
nd assessment of RWMA, at the cost of increasing the
reath hold (14). Second, late-enhancement imaging was
erformed in the majority of patients. The feasibility of the
onger research protocol in a clinical setting remains to be
stablished. Third, study patients with frequent ventricular
xtrasystoles were placed on antiarrhythmic medication
efore scanning to reduce interference with ECG gating.
inally, the specificity of 78% raises the possibility that the
eaders had a relatively low threshold for classifying studies
s Suspicious; that the area under the ROC curve was 0.98
onetheless affirms the diagnostic value of CMR.
The negative predictive value of CMR in the genotyped
ample was 88%. The sole false-negative result was a
2-year-old boy with mild RV RWMA of uncertain signif-
cance. The absence of more prominent morphologic
hanges may be a corollary of age-related penetrance in
RVC; clinical manifestations are uncommon before ado-
escence. Nevertheless, it should be emphasized that a
ormal CMR study does not exclude ARVC. Postmortem
tudies show that fibrofatty replacement is frequently mi-
roscopic rather than overt, and hence not discernible by
maging (1). Furthermore, ventricular arrhythmia has been
eported in a Naxos patient without apparent histologic
ubstrate (2). The limitations of any imaging modality in
xcluding ARVC are therefore underscored. Likewise, we
o not advocate the use of CMR, or any single investiga-
ion, as a sole screening test for ARVC, although our results
trongly support inclusion of CMR as part of a comprehen-
ive noninvasive workup.
In their study of 2-dimensional echocardiography in
robands with ARVC, Yoerger et al. (20) highlighted the
mportance of quantifying RV enlargement and dysfunc-
ion. Consistent with their findings was the notable diag-
ostic accuracy of RV volume analysis in our cross-
omparison of key CMR parameters. Another strong
eature was LV LE, occurring in a subepicardial or midwall
attern distinct from the subendocardial involvement ob-
erved in ischemic heart disease (7). Specific genotype–
henotype associations may, however, have skewed the
esults; of the 26 gene-positive individuals in our sample, 16
62%) had desmoplakin mutations. Frequent and marked
V involvement has been reported in several families with
efects in desmoplakin (2,4). Unequivocal RV LE was less
ommonly identified, a probable corollary of protocol de-
ign; inversion times were set to null the LV myocardium,
nd the inversion recovery sequence was not fat-suppressed.
bnormal trabeculation has been reported in over half of
RVC probands assessed by echocardiography and CMR
12,20). Although a similar proportion of gene carriers in
ur study showed this feature, it was also observed in 4 sene-negative individuals, resulting in a low specificity
56%).
CMR studies were frequently assigned a Possible rating
n the presence of soft signs such as abnormal trabeculation,
ild localized dilation, and subtle RWMA. Around half of
hese patients had nonspecific ECG abnormalities and
upraventricular or low-grade ventricular arrhythmia, rais-
ng suspicion of early ARVC. Nevertheless, the results of
enotype analysis indicate that, with one exception, patients
n the Possible category were not affected. In the concealed
hase of ARVC, morphologic abnormalities may be dis-
ernible only by highly sensitive imaging techniques, CMR
nd contrast-enhanced echocardiography being the main
andidates. Operators in both modalities may be susceptible
o over-reading because the spectrum of normal morphol-
gy and function within the thin-walled, trabeculated,
yramidal RV remains to be defined.
Reproducibility therefore remains a central issue in the
ssessment of ARVC by CMR. Intraobserver concordance
as excellent for the main operator, suggesting that pattern
ecognition may be learned. Strengthening this premise is
he high interobserver concordance (kappa  0.84) shown
y one of the readers, who had reported 150 ARVC scans
longside the main operator prior to involvement in the
tudy. Concordance was lowest (although still moderate) for
he reader with the least pre-study and intra-study experi-
nce, and limited background knowledge of ARVC. These
reliminary findings suggest 3 key factors in improving
eproducibility for an individual CMR reviewer: extensive
xperience with reporting ARVC scans, understanding of
he clinical manifestations and pathogenesis of ARVC, and
raining alongside an expert reader to learn pattern recog-
ition. At a broader level, CMR will realize its full potential
s a diagnostic tool in ARVC only after systematic evalua-
ion of a large genotyped population, who represent the
deal patients for comparing the changes of early disease
ith normal variants. The preliminary data yielded by our
tudy should provide impetus for further work in this
mportant area.
tudy limitations. Key limitations include the case mix,
hich is not wholly representative of the patient population
een at other institutions. Our sample included a prepon-
erance of relatives undergoing familial evaluation (82%),
eflecting the special interests of our center; only 18% were
eferred for symptomatic profiling, the predominant reason
or assessment elsewhere.
The main CMR operator was considered unblinded
wing to her role as a clinician treating study patients.
amiliarity with clinical details is a representation of reality,
ince referring physicians commonly provide a summary of
rior investigations, but raises the possibility of systematic
ias. This was reduced by involvement of at least 2 inde-
endent readers with each case. Furthermore, the high level
f concordance achieved on blinded viewing 12 months later
upports the validity of the original categorizations.
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Reassessing the Role of CMR in ARVC November 21, 2006:2132–40onclusions. In spite of controversies surrounding its role
n ARVC, CMR is a valuable diagnostic tool that comple-
ents echocardiography and substantially enhances the
ensitivity of clinical diagnosis, particularly in early disease.
onsistent with this was the 96% sensitivity and 78%
pecificity of CMR in the genotyped subset of patients, only
6% of whom satisfied TF criteria. Incorporation of CMR
esults would have enabled TF diagnosis in a further 30% of
roven gene carriers, and in 75% of patients who prospec-
ively satisfied modified criteria only. Since accuracy and
eproducibility are strongly operator dependent, however,
MR evaluation of ARVC may be best conducted at
pecialist centers, using a dedicated comprehensive protocol,
y experts with a clinical background in the field and
xtensive experience in analysis of volumes, RV RWMA,
nd delayed-enhancement imaging.
cknowledgments
he authors would like to thank Sripurna Das, PhD, for her
elpful comments on the manuscript. This work is dedi-
ated to the memory of Asifa Quraishi, MBBS, MRCP.
eprint requests and correspondence: Dr. Srijita Sen-Chowdhry or
rofessor William J. McKenna, Cardiology In The Young, The
eart Hospital, 16–18 Westmoreland Street, London W1G 8PH,
nited Kingdom. E-mail: srijita@doctors.org.uk or william.
ckenna@uclh.nhs.uk.
EFERENCES
1. Sen-Chowdhry S, Lowe MD, Sporton SC, McKenna WJ. Arrhyth-
mogenic right ventricular cardiomyopathy: clinical presentation, diag-
nosis, and management. Am J Med 2004;117:685–95.
2. Sen-Chowdhry S, Syrris P, McKenna WJ. Genetics of right ventric-
ular cardiomyopathy. J Cardiovasc Electrophysiol 2005;16:927–35.
3. Pilichou K, Nava A, Basso C, et al. Mutations in desmoglein-2 gene
are associated with arrhythmogenic right ventricular cardiomyopathy.
Circulation 2006;113:1171–9.
4. Bauce B, Basso C, Rampazzo A, et al. Clinical profile of four families
with arrhythmogenic right ventricular cardiomyopathy caused by
dominant desmoplakin mutations. Eur Heart J 2005;26:1666–75.5. Syrris P, Ward D, Asimaki A, et al. Clinical expression of
plakophilin-2 mutations in familial arrhythmogenic right ventricular
cardiomyopathy. Circulation 2006;113:356–64.
6. Hamid MS, Norman M, Quraishi A, et al. Prospective evaluation of
relatives for familial arrhythmogenic right ventricular cardiomyopathy/
dysplasia reveals a need to broaden diagnostic criteria. J Am Coll
Cardiol 2002;40:1445–50.
7. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ.
Visualisation of presence, location, and transmural extent of healed
Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:
21–8.
8. Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection
of myocardial fibrosis in arrhythmogenic right ventricular cardiomy-
opathy using delayed-enhancement magnetic resonance imaging. J Am
Coll Cardiol 2005;45:98–103.
9. Bluemke DA, Krupinski EA, Ovitt T, et al. MR imaging of arrhyth-
mogenic right ventricular cardiomyopathy: morphologic findings and
interobserver reliability. Cardiology 2003;99:153–62.
0. Tandri H, Calkins H, Marcus FI. Controversial role of magnetic
resonance imaging in the diagnosis of arrhythmogenic right ventricular
dysplasia. Am J Cardiol 2003;92:649.
1. White JB, Razmi R, Nath H, Kay GN, Plumb VJ, Epstein AE.
Relative utility of magnetic resonance imaging and right ventricular
angiography to diagnose arrhythmogenic right ventricular cardiomy-
opathy. J Interv Card Electrophysiol 2004;10:19–26.
2. Tandri H, Calkins H, Nasir K, et al. Magnetic resonance imaging
findings in patients meeting task force criteria for arrhythmogenic right
ventricular dysplasia. J Cardiovasc Electrophysiol 2003;14:476–82.
3. Simonetti OP, Finn JP, White RD, Laub G, Henry DA. “Black
blood” T2-weighted inversion-recovery MR imaging of the heart.
Radiology 1996;199:49–57.
4. Miller S, Simonetti OP, Carr J, Kramer U, Finn JP. MR Imaging of
the heart with cine true fast imaging with steady-state precession:
influence of spatial and temporal resolutions on left ventricular
functional parameters. Radiology 2002;223:263–9.
5. Maceira AM, Prasad SK, Khan M, Pennell DJ. Normalized left ventric-
ular systolic and diastolic function by steady state free precession cardio-
vascular magnetic resonance. J Cardiovasc Magn Reson 2006;8:417–26.
6. Maceira AM, Prasad SK, Pennell DJ. Reference right ventricular
systolic and diastolic function normalized to age, gender and body
surface area from steady state free precession cardiovascular magnetic
resonance. Eur Heart J 2006. In press.
7. VassarStats. Available at: http://faculty.vassar.edu/lowry/vshome.html.
Accessed July 10, 2006.
8. Eng J. ROC analysis: web-based calculator for ROC curves. Available
at: http://www.rad.jhmi.edu/jeng/javarad/roc/JROCFITi.html. Ac-
cessed July 10, 2006.
9. Midiri M, Finazzo M, Brancato M, et al. Arrhythmogenic right
ventricular dysplasia: MR features. Eur Radiol 1997;7:307–12.
0. Yoerger DM, Marcus F, Sherrill D, et al. Echocardiographic findings
in patients meeting task force criteria for arrhythmogenic right
ventricular dysplasia: new insights from the multidisciplinary study of
right ventricular dysplasia. J Am Coll Cardiol 2005;45:860–5.
